Medical Sciences Teaching Centre
University of Oxford
South Parks Road
Registration opens at 6:00pm
Oxford Biotech would like to invite you to our major event in Oxford this Thursday, 4th of December in the Medical Sciences Teaching Centre, University of Oxford. Oxford is only one hour's travel from London Universities and a simple train journey from other universities further afield.
A panel of key speakers from academia and industry will discuss what Open Innovation is and how it will transform both startups and the pharmaceutical industry. Individual talks are followed by an interactive panel discussion. The evening will conclude with a drinks reception, providing the perfect opportunity for networking and further discussion. Our events are attended by academic scientists, business students, entrepreneurs, and members of industry alike, creating an ideal environment for meeting people with innovative ideas or thoughts on how to move those ideas forward.
Are wondering about how Open Innovation can turn your science into a million pound startup company?
Our event will finish with an announcement that will make exactly that possible, so join us at the 4th of December!
The event is free to attend, and open to all OB members.
Speakers & Panellists:
Prof. Andrew Hamilton - Vice Chancellor, University of Oxford Prof. Chas Bountra- Chief Scientist SGC Prof. Birgitte Andersen- CEO Big Innovation Centre Dr. Mark Whittaker- SVP Drug Discovery, Evotec Dr. Hitesh Sanganee - Director Emerging Innovation, AstraZeneca Dr. Trevor Howe - Director External Innovations, Discovery Sciences Janssen - Johnson & Johnson
Event background The past 60 years have seen huge advances in many of the scientific, technological and managerial factors that should have raised the efficiency of commercial drug research and development (R&D). Yet the number of new drugs approved per billion US dollars spent on R&D has halved roughly every 9 years since 1950, falling around 80-fold in inflation-adjusted terms.
The event shall introduce Open Innovation as a platform that lowers collaboration barriers between investigators from different organisations and fields and promotes the sharing of ideas thereby accelerating innovation and creating new opportunities for the big Pharma and small startups alike.